Clinical Trials Directory

Trials / Completed

CompletedNCT06064838

Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC)

Effects of Cacao Flavonoids in Long COVID-19 Patients with Chronic Fatigue (FLALOC)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Guillermo Ceballos Reyes · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The study use a triple blind, placebo-controlled design enrolling male and female subjects between 30-70 yo to evaluate the effect of daily consumption of a cacao supplement on inflammation, endothelial damage, handgrip strength, fatigue scale and quality of life.

Detailed description

The study use a triple blind, placebo-controlled design enrolling male and female subjects between 30-70 yo distributed homogeneously at random in two groups: the control group (Placebo) and the intervention group (Cacao Flavonoids) both groups affected for 90 days. The variables to consider will be: Interleukins (IL-1b, IL-6), Tumoral Necrosis Factor alpha (TNF-α) and syndecan-1. For physical performance is evaluated the handgrip strength. The investigators also assessed quality of life using the Health Related QoL (EQ-5D) questionnaire, and the numerical fatigue rating scale.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFlavonoids1 capsule every 12h for 90 days

Timeline

Start date
2023-08-01
Primary completion
2024-08-01
Completion
2024-09-30
First posted
2023-10-03
Last updated
2024-10-01

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT06064838. Inclusion in this directory is not an endorsement.

Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC) (NCT06064838) · Clinical Trials Directory